Clinical Trials at Skin Health Institute

13/03/2026

Congratulations to the Australasian Dermatology Registry team on their recent publication ‘Real-World Efficacy and Drug Survival of Adalimumab in Australian Patients With Psoriasis’ in the Australasian Journal of Dermatology.

The study evaluated the real-world efficacy and drug survival of Adalimumab for moderate-to-severe chronic plaque psoriasis using data from the Australasian Dermatology Registry. Outcomes from Australian clinical practice were compared with results from the Phase 3 REVEAL trial and its open-label extension.

The findings showed that adalimumab maintained strong effectiveness in real-world practice, with stable PASI90 responses over three years and drug survival of around 28 months. Achieving low disease activity (PASI ≤2) and male s*x were associated with longer treatment persistence, supporting the continued effectiveness of adalimumab in routine psoriasis care.

Check out the publication now via the link below. https://lnkd.in/ghAUcKsx

The ADR is a national collaboration between dermatologists, facilitated by the Skin Health Institute a centre of excellence committed to best practice patient care.

07/03/2026

This International Women’s Day, we celebrate the incredible women of the Skin Health Institute who make our work possible every day.

Across our organisation, women play a vital role in delivering our three pillars - education, research and treatment. Their expertise, compassion and dedication ensure we can continue advancing skin health and provide the highest level of care to our patients.

Today, we recognise and thank the remarkable women whose work drives our mission forward.

04/02/2026

Today marks World Cancer Day, highlighting the importance of cancer prevention, early detection, evidence-based treatment, and ongoing research.

Skin cancer is the most commonly diagnosed cancer in Australia, with around two in three Australians developing it by the age of 70.

At the Skin Health Institute, our work focuses on improving skin cancer outcomes through specialist care, education, and clinical research, supporting both patients and health professionals.

14/01/2026

The Skin Health Institute hopes everyone had a safe and restful holiday period. Our thoughts are with the communities across Victoria impacted by the recent and ongoing bushfires, and we extend our support to those affected.

As we move into 2026, our clinics are now open and we look forward to continuing to provide high-quality dermatological care to our patients throughout the year.

01/09/2025

The Skin Health Institute and our Director of Research A/Prof Peter Foley were recently featured on 7NEWS highlighting a groundbreaking collaboration with the University of Melbourne, where a new artificial intelligence (AI) tool is transforming the way skin cancer is detected.

Unlike traditional methods that rely on visual inspections and biopsies, this handheld, non-invasive technology integrates AI with thermal multimodal imaging to identify abnormal lesions in real time. In a recent pilot study conducted at SHI, the tool achieved a 94 per cent diagnostic accuracy, with clinicians and patients praising its ease of use and clinical value.

This innovation has the potential to save lives through earlier detection, reduce the number of unnecessary biopsies performed each year, cut healthcare costs, and improve equity by working effectively across all skin tones. Importantly, it could also increase access to care for rural and remote communities where specialist services are limited.

Congratulations to Dr Noor E Karishma Shaik, A/Prof Foley, and the research team on this exciting step forward in dermatological innovation.

You can view the full 7NEWS feature via the link: https://www.youtube.com/watch?v=yrL76kPYfao

01/09/2025

Do you have moderate to severe acne?

The Skin Health Institute is conducting a new clinical research study exploring the potential benefits of an injectable vaccine treatment for facial acne, and you may be eligible to take part.

We’re currently seeking men and women aged 18 - 45 with moderate to severe acne to help us improve future treatment optiThis study has been approved by the Bellberry Human Research Ethics Committee. ons for this condition.

Participants will receive expert care from our experienced dermatology research team, with no cost to take part and all study-related expenses reimbursed.

Interested in taking part?

Contact our Trial Manager, Sarah, at schivers@skinhealthinstitute.org.au or
register your interest here:

Back DO YOU HAVE ACNE? Adults aged 18 to 45 years who have facial acne, may qualify for this clinical research trial and receive investigational injected vaccine treatment (active study drug) or placebo. Eligible participants must have a clinical diagnosis of moderate or severe facial acne vulgaris,...

05/06/2025

This week marks Hidradenitis Suppurativa (HS) Awareness Week - a vital opportunity to educate the community about this often misunderstood chronic skin condition.
The week aims to shine a light on HS and foster connection among patients, caregivers, healthcare professionals, and advocates. By raising awareness, challenging misconceptions, and promoting understanding, we can provide meaningful support to those living with HS.
At the Skin Health Institute, we’re committed to helping HS patients navigate diagnosis, treatment, and long-term care. Our dermatology specialists offer expert, personalised care tailored to each individual’s needs.
We are currently recruiting participants for a clinical trial focused on HS. If you’re interested in learning more, please follow the link below or contact Sarah Chivers at schivers@skinhealthinstitute.org.au.
https://skinhealthinstitute.org.au/clinic.../current-trials/
Let’s come together to raise awareness, encourage early diagnosis, and promote better outcomes for those affected by HS. Join us in supporting HS Awareness Week and sharing the message of hope, support, and improved quality of life.

20/05/2025

Celebrating International Clinical Trials Day!

Today, we proudly celebrate International Clinical Trials Day by recognising the outstanding work of our Clinical Trials team at the Skin Health Institute, and the invaluable contribution of our clinical trial participants. Their dedication is fundamental to advancing dermatological research and improving patient outcomes.

With more than 30 years of experience, the Skin Health Institute’s clinical trials unit is widely regarded as a leader in dermatology research in Australia. Having conducted over 150 clinical trials, the unit has played a key role in the development of many therapies that are now readily available to patients across the country. This work is central to our mission of delivering world-class, evidence-based dermatological care.

Led by Associate Professor Peter Foley and Sarah Chivers, our team includes experienced nurses, coordinators, support staff, and two Clinical Trial Research Fellows for 2025. Each member is dedicated to providing innovative treatment options for our patients and making a meaningful impact on the broader community.
In the lead-up to today, we spoke with Asami, our Clinical Trials Coordinator, about what she finds most rewarding in her role on the team.

To learn more about our clinical trials at the Skin Health Institute, tune in to our episode of the Spot Diagnosis podcast featuring A/Prof Peter Foley and Sarah Chivers. In this episode, we explore the vital role clinical trials play in advancing dermatological treatments and improving skin health.
Listen via the link below.
https://skinhealthinstitute.org.au/spot.../clinical-trials/
https://skinhealthinstitute.org.au/clinical-trials/

11/02/2025

Do you or someone you know have psoriasis?

The Skin Health Institute is currently recruiting for a new psoriasis study.

For more information about this trial, please contact our Trials Manager, Sarah Chivers, schivers@skinhealthinstitute.org.au.

If you would like to register your interest, visit the link below.
https://skinhealthinstitute.org.au/clinical-trials/current-trials/do-youhave-a-diagnosis-of-plaque-psoriasis-2/

14/01/2025

Do you or someone you know have deep frown lines between your eyebrows (also known as glabellar lines)?

If you are over the age of 18, you may be eligible for our new clinical trial focused on the potential treatment of glabellar lines.

You can register your interest via the link below.
https://skinhealthinstitute.org.au/clinical-trials/general-information/how-to-register-for-a-clinical-trial/

03/12/2024

Do you or someone you know experience chronic intermittent itchy skin bought on by heat, cold or exercise?

You may qualify for our currently recruiting study on Chronic Inducible Urticaria.

Please follow the link to our website to learn more.
https://lnkd.in/g6Vy3t4P

13/09/2024

Do you or someone you know have atopic dermatitis?

The Skin Health Institute is currently recruiting for a new atopic dermatitis study.

For more information about this trial, please contact our Trials Manager, Sarah Chivers, schivers@skinhealthinstitute.org.au.

If you would like to register your interest, visit the link below.
https://skinhealthinstitute.org.au/clinical-trials/general-information/how-to-register-for-a-clinical-trial/